Literature DB >> 8220873

Characterization of P2-purinoceptor mediated cyclic AMP formation in mouse C2C12 myotubes.

R H Henning1, M Duin, A den Hertog, A Nelemans.   

Abstract

1. The formation of adenosine 3':5'-cyclic monophosphate (cyclic AMP) and inositol(1,4,5)trisphosphate (Ins(1,4,5)P3), induced by ATP and other nucleotides was investigated in mouse C2C12 myotubes. 2. ATP (100 microM) and ATP gamma S (100 microM) caused a sustained increase in cyclic AMP content of the cells, reaching a maximum after 10 min. The cyclic AMP content reached a maximum in the presence of 100 microM ATP, followed by a decline at higher ATP concentrations. ATP-induced cyclic AMP formation was inhibited by the P2-purinoceptor antagonist, suramin. 3. Myotubes hydrolysed ATP to ADP at a rate of 9.7 +/- 1.0 nmol mg-1 protein min-1. However, further hydrolysis of ADP to AMP and adenosine was negligible. 4. The cyclic AMP formation induced by ADP (10 microM-1 mM) showed similar characteristics to that induced by ATP, but a less pronounced decline was observed than with ATP. ADP-induced cyclic AMP formation was blocked by suramin, while cyclic AMP formation elicited by adenosine (10 microM-1 mM) was insensitive to suramin. 5. The ATP analogue, alpha,beta-methylene-ATP also induced a suramin-sensitive cyclic AMP formation, while 2-methylthio-ATP and the pyrimidine, UTP, did not affect cyclic AMP levels. 6. Stimulation of the myotubes with ATP or UTP (10 microM-1 mM) caused a concentration-dependent increase in the Ins(1,4,5)P3 content of the cells. ADP (100 microM-1 mM) was less effective. Adenosine did not affect Ins(1,4,5)P3 levels. 7. Incubation of the cells with UTP (30 microM- 1 mM) inhibited the ATP- and ADP-induced cyclic AMP formation, suggesting that stimulation of the 'nucleotide' type P2-receptor inhibits P2-purinoceptor mediated cyclic AMP formation in C2C12 myotubes. In contrast, UTP (30 microM-I mM) enhanced adenosine-induced cyclic AMP formation.8. Adenosine-sensitive P1-purinoceptors activating cyclic AMP formation were found in C2C12 myotubes.Further, a novel P2-purinoceptor is postulated, sensitive to ATP, ADP and ATPgammaS, which also activates the formation of cyclic AMP in C2C12 myotubes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8220873      PMCID: PMC2176000          DOI: 10.1111/j.1476-5381.1993.tb13782.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  35 in total

1.  Regulation of muscle acetylcholine receptor synthesis in vitro by cyclic nucleotide derivatives.

Authors:  H Betz; J P Changeux
Journal:  Nature       Date:  1979-04-19       Impact factor: 49.962

2.  A possible involvement of cyclic AMP in the expression of desensitization of the nicotinic acetylcholine receptor. A study with forskolin and its analogs.

Authors:  E X Albuquerque; S S Deshpande; Y Aracava; M Alkondon; J W Daly
Journal:  FEBS Lett       Date:  1986-04-07       Impact factor: 4.124

3.  Protein kinase C phosphorylates the inhibitory guanine-nucleotide-binding regulatory component and apparently suppresses its function in hormonal inhibition of adenylate cyclase.

Authors:  T Katada; A G Gilman; Y Watanabe; S Bauer; K H Jakobs
Journal:  Eur J Biochem       Date:  1985-09-02

4.  A simple and sensitive saturation assay method for the measurement of adenosine 3':5'-cyclic monophosphate.

Authors:  B L Brown; J D Albano; R P Ekins; A M Sgherzi
Journal:  Biochem J       Date:  1971-02       Impact factor: 3.857

5.  Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle.

Authors:  D Yaffe; O Saxel
Journal:  Nature       Date:  1977 Dec 22-29       Impact factor: 49.962

6.  Subclasses of external adenosine receptors.

Authors:  C Londos; D M Cooper; J Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

7.  Calcium release from separate receptor-specific intracellular stores induced by histamine and ATP in a hamster cell line.

Authors:  A Den Hertog; B Hoiting; A Molleman; J Van den Akker; M Duin; A Nelemans
Journal:  J Physiol       Date:  1992-08       Impact factor: 5.182

8.  Tumour promoter uncouples beta-adrenergic receptor from adenyl cyclase in mouse epidermis.

Authors:  S J Garte; S Belman
Journal:  Nature       Date:  1980-03-13       Impact factor: 49.962

9.  cAMP-dependent protein kinase phosphorylates the nicotinic acetylcholine receptor.

Authors:  R L Huganir; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

10.  Enhancement of adenylate cyclase activity in S49 lymphoma cells by phorbol esters. Withdrawal of GTP-dependent inhibition.

Authors:  J D Bell; L L Brunton
Journal:  J Biol Chem       Date:  1986-09-15       Impact factor: 5.157

View more
  11 in total

Review 1.  Purinergic signalling in the musculoskeletal system.

Authors:  Geoffrey Burnstock; Timothy R Arnett; Isabel R Orriss
Journal:  Purinergic Signal       Date:  2013-08-14       Impact factor: 3.765

2.  Extracellular ATP signaling during differentiation of C2C12 skeletal muscle cells: role in proliferation.

Authors:  Tiziana Martinello; Maria Cristina Baldoin; Laura Morbiato; Maddalena Paganin; Elena Tarricone; Giorgio Schiavo; Elisa Bianchini; Dorianna Sandonà; Romeo Betto
Journal:  Mol Cell Biochem       Date:  2011-02-10       Impact factor: 3.396

Review 3.  Purinergic signaling in embryonic and stem cell development.

Authors:  Geoffrey Burnstock; Henning Ulrich
Journal:  Cell Mol Life Sci       Date:  2011-01-08       Impact factor: 9.261

4.  Differential modulation of voltage-activated conductances by intracellular and extracellular cyclic nucleotides in leech salivary glands.

Authors:  B Everill; M S Berry
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

5.  Synergistic effects of adenosine A1 and P2Y receptor stimulation on calcium mobilization and PKC translocation in DDT1 MF-2 cells.

Authors:  Bertil B Fredholm; Jean W Assender; Eva Irenius; Noriko Kodama; Naoaki Saito
Journal:  Cell Mol Neurobiol       Date:  2003-06       Impact factor: 5.046

6.  Different mechanisms of Ca2(+)-handling following nicotinic acetylcholine receptor stimulation, P2U-purinoceptor stimulation and K(+)-induced depolarization in C2C12 myotubes.

Authors:  R H Henning; M Duin; J P van Popta; A Nelemans; A den Hertog
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

Review 7.  Purinergic signalling during development and ageing.

Authors:  Geoffrey Burnstock; Nicholas Dale
Journal:  Purinergic Signal       Date:  2015-05-20       Impact factor: 3.765

8.  Characterization of specific GTP binding sites in C2C12 mouse skeletal muscle cells.

Authors:  Tiziana Pietrangelo; Maria A Mariggiò; Paola Lorenzon; Stefania Fulle; Feliciano Protasi; Michel Rathbone; Eva Werstiuk; Giorgio Fanò
Journal:  J Muscle Res Cell Motil       Date:  2002       Impact factor: 3.352

9.  P2 nucleotide receptors on C2C12 satellite cells.

Authors:  Wiktor Banachewicz; Dorota Supłat; Patryk Krzemiński; Paweł Pomorski; Jolanta Barańska
Journal:  Purinergic Signal       Date:  2005-07-29       Impact factor: 3.765

10.  Stimulation of Xenopus P2Y1 receptor activates CFTR in A6 cells.

Authors:  L Guerra; M Favia; T Fanelli; G Calamita; M Svetlo; A Bagorda; K A Jacobson; S J Reshkin; V Casavola
Journal:  Pflugers Arch       Date:  2004-10       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.